Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.05% | 41.94 | 0.9% | $954.26m | |
| JNJ | Johnson & Johnson | 0.04% | 138.89 | 0.7% | $780.65m | |
| MRK | Merck & Co., Inc. | 0.22% | 81.20 | 0.6% | $745.47m | |
| BMY | Bristol-Myers Squibb Company | -0.99% | 46.83 | 1.4% | $627.82m | |
| LLY | Eli Lilly and Company | 0.04% | 116.86 | 1.0% | $478.55m | |
| ABBV | AbbVie, Inc. | -1.32% | 80.08 | 2.2% | $408.18m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.96% | 39.03 | 1.3% | $191.83m | |
| NVS | Novartis AG Sponsored ADR | 3.62% | 87.50 | 0.2% | $171.58m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 0.48% | 40.18 | 0.2% | $97.11m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 0.43% | 48.59 | 0.1% | $65.75m | |
| SNY | Sanofi Sponsored ADR | 0.40% | 42.28 | 0.2% | $49.55m | |
| LCI | Lannett Company, Inc. | -7.14% | 5.66 | 36.7% | $9.52m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -2.14% | 2.29 | 1.6% | $0.41m | |
| EPIX | ESSA Pharma Inc | 21.95% | 2.50 | 0.1% | $0.02m |
Company Profile
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.